- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06014346
Prevention of Vasovagal Reactions in First-time Blood Donors Using a Combined PSYchological and Physiological Approach (PREDONPSY)
Prospective Study of the Prevention of Vasovagal Reactions in First-time Whole Blood Donors Using a Combined PSYchological and Physiological Approach: PREDONPSY
The prevention of vasovagal reactions (VVR) occurring during or after donation is a major issue for the French Blood Establishment (EFS), firstly to guarantee the safety of donors but also to retain them, as this reaction is one of the negative experiences affecting the return to donation.
The EVASION study conducted in the Auvergne Rhône-Alpes region (AURA) on 4828 donors representative of the French donor population, reported a beneficial effect of muscle contraction exercises to prevent the occurrence of VVR during donation, while hydric solutions, and even more so isotonic solutions, were likely to decrease the frequency of delayed VVR.
These preventive measures have been integrated into the internal guidelines and currently include muscular and breathing exercises and hydration. Nevertheless, the isotonic solution could not be routinely deployed for feasibility and cost reasons. A salty snack could replace the isotonic solution to produce the same effects with better feasibility and acceptability. Furthermore, a significant proportion of discomfort is psychological in origin, related to stress and anxiety which persist despite these measures, particularly in the first-time donor population.
These measures, which are mainly focused on the prevention of VVR of physiological origin, are still insufficient and can be optimized and complemented to reduce the occurrence of VVR, especially in first-time donors for whom anxiety and stress play an important role in the etiology of VVR.
Two measures could further reduce the occurrence of VVR:
- Reinforcement of the physiological strategy: ingestion of a salty snack before donation, the effect of which could be similar to the effect of the isotonic solution, which could not be delivered in practice because of its cost following the data of the EVASION study.
- Addition of a psychological strategy: flyer given at the interview presenting the four most frequent fears as well as a description of the recommended muscular and respiratory exercises, followed by the execution of the recommended exercises before the sampling.
Hypothesis is that the combination of a psychological and physiological strategies would allow a reduction of the occurrence of immediate and/or 48 h delayed VVR during the whole blood donation in first time donors compared to the current practices.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Brice MD POREAU
- Phone Number: +33 478 656 137
- Email: brice.poreau@efs.sante.fr
Study Contact Backup
- Name: Julie MD-PhD HAESEBAERT
- Phone Number: +33 472 115 732
- Email: julie.haesebaert@chu-lyon.fr
Study Locations
-
-
-
Lyon, France, 69153
- French Blood Establishment (EFS)
-
Contact:
- Brice MD POREAU, MD/PhD
- Phone Number: +33 478 656 137
- Email: brice.poreau@efs.sante.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- M/F between 18 and 70 years old,
- A first-time donor who wishes to donate blood in Lyon, either at a fixed site or at a mobile unit,
- Declared fit to donate whole blood after the EFS pre-donation interview,
- Weight ≥ 50kg and height ≥ 135 cm,
- Available for telephone contact between to 5d +/- 2 days after donation,
- Having signed a written consent to participate in the study.
Non-inclusion criteria:
- Known allergy to shellfish, and/or gluten, and/or milk, and/or soy,
- Incomprehension of the French language,
- First-time donor under protective measures (guardian, curator) or any other administrative measure,
- Not affiliated to the French social security system or any other equivalent system,
- Pregnant or breastfeeding woman,
- Subject participating in any other interventional or non-interventional research
Exclusion Criteria:
- Withdrawal of consent
- First-time donor with anemia following routine hemoglobin testing
- First-time donor not reachable for telephone interview
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
EFS usual standard practices for the whole blood donation
|
|
Experimental: Test Group 1
A psychological strategy is added to EFS standard practices before the whole blood donation
|
|
Experimental: Test Group 2
A physiological strategy is added to EFS standard practices before the whole blood donation : - Ingesting a salty snack.
|
- ingesting a salty snack
|
Experimental: Test group 3
The both psychological and physiological strategies are added to EFS standard practices before the whole blood donation
|
- ingesting a salty snack
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vasovagal reactions (VVR)
Time Frame: Day 1 = donation day ; Day 3 = 48h post donation
|
Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by both psychological and physiological strategies (group 4) compared to usual standard practices (group 1)
|
Day 1 = donation day ; Day 3 = 48h post donation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VVR psychological strategy
Time Frame: Day 1 = donation day ; Day 3= 48h post donation
|
Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by psychological strategy (group 2) compared to usual standard practices (group 1)
|
Day 1 = donation day ; Day 3= 48h post donation
|
VVR physiological strategy
Time Frame: Day 1 = donation day ; Day 3= 48h post donation
|
Proportion of first-time donors experiencing VVR (immediate and delayed up to 48 hours) during whole blood donation managed by physiological strategy (group 3) compared to usual standard practices (group 1)
|
Day 1 = donation day ; Day 3= 48h post donation
|
Immediate VVR
Time Frame: Day 1 = donation day, before leaving the centre
|
Proportion of first-time donors with immediate VVR compared between the groups
|
Day 1 = donation day, before leaving the centre
|
Delayed VVR
Time Frame: Day 3= 48h post donation
|
Proportion of first-time donors with delayed VVR compared between the groups
|
Day 3= 48h post donation
|
First-time donor adherence
Time Frame: Day 1 = donation day, before leaving the centre
|
Adherence of the primary donor to the study strategies and to the EFS recommendations (complete intake of salty snacks, hydration, performance of muscle and breathing exercises training, performance of muscle and breathing exercises during donation, compliance with the duration of post-donation monitoring stage).
|
Day 1 = donation day, before leaving the centre
|
First-time donor retention
Time Frame: Month 12 following the first-time donation
|
Compared between the groups the number of first-time donors who made a second blood donation in the 12 months following the first-time donation, collected by query from the EFS computerized file
|
Month 12 following the first-time donation
|
Anxiety/fear
Time Frame: Day 1 = donation day, before donation
|
Assessment of the evolution of the "anxiety/fear" score between arrival and before the whole blood donation, compared between the groups. This questionnaire consists of the 6-item Blood Donor Anxiety Scale (BDAS) (5-point Likert scale) (Chell et al., 2016) and a 4-item component with a 5-point Likert scale that allows for an assessment of the 4 most common donor fears (of the needle, to see blood, to feel pain, to experience sensations of discomfort). The scoring is obtained by summing up the responses to the different items. Score is between 10 and 50, a higher score is associated to a better outcome. |
Day 1 = donation day, before donation
|
Sense of control and fears
Time Frame: Day 1 = donation day, before donation
|
Assessment of the "sense of control and fears" score, compared between the groups. The concepts measured here are the feeling of control related to giving blood (5 items) and the feeling of control over fears (4 items) according to a 5-point Likert scale. The scoring is obtained by summing up the answers to the different items. Score is between 9 and 45, a higher score is associated to a better outcome. |
Day 1 = donation day, before donation
|
Feelings of discomfort
Time Frame: Day 1 = donation day, after donation and before leaving the centre
|
Assessment of the "feelings of discomfort" score, compared between the groups. The BDRI (Blood Donation Reactions Inventory) (France et al., 2008) provides an assessment of the subjective evaluation of 11 pre-syncopal symptoms (5-point Likert scale). The BDRI is easily understood by donors and is rapid. The BDRI provides important information about the donor experience to predict satisfaction and likelihood of re-donation. The score is calculated by summing up the responses to the various items. Score is between 11 and 55, a higher score is associated to a worse outcome. |
Day 1 = donation day, after donation and before leaving the centre
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL22_0131
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vasovagal Reaction
-
Vestre Viken Hospital TrustUllevaal University Hospital; Ostfold Hospital Trust; Sahlgrenska University...Not yet recruitingColorectal Cancer | Colorectal Neoplasia | Screening Colonoscopy | Colorectal Cancer Screening | Vasovagal Reaction
-
University of CalgaryNot yet recruitingSyncope | Vasovagal Syncope (VVS)Canada
-
Boston Scientific CorporationCompletedVasovagal Syncope | Arhythmia | Atrioventricular Heart-block | Chronic Bundle Branch or Branch Block | Carotid Sinus Hypersensitivity Reaction SyndromeChina
-
University of CalgaryRecruiting
-
Dr. Bob SheldonVanderbilt UniversityActive, not recruitingVasovagal SyncopeUnited States, Canada, Poland
-
University of CalgaryCardiac Arrhythmia Network of CanadaCompleted
-
University of CalgaryVanderbilt UniversityActive, not recruitingVasovagal SyncopeCanada
-
Aarhus University Hospital SkejbyAarhus University Hospital; Biotronik SE & Co. KGCompleted
-
Hospital de Clinicas de Porto AlegreUnknown
Clinical Trials on Psychological strategy
-
Jiangsu Taizhou People's HospitalRecruitingEnd Stage Renal Disease on DialysisChina
-
Varduhi PetrosyanGrand Challenges Canada; National Tuberculosis Control Center, Ministry of...Completed
-
Centre Hospitalier Universitaire de BesanconUnknownPrimary Headache DisorderFrance
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingBlood Pressure | Psychological StressUnited States
-
Guangxi Medical UniversityCompletedBurnout | PsychologicalChina
-
Alexandria UniversityCompletedPsychological Distress | ResilienceEgypt
-
China National Center for Cardiovascular DiseasesUnknown
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknown
-
Centre Hospitalier Universitaire de NīmesCompletedCentral Venous CatheterizationFrance
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompleted